Functional analysis of ATM with relevance for primary immunodeficiency and tumor formation
Author: Lähdesmäki, Aleksi
Date: 2004-04-29
Location: Sal9Q, Alfred Nobels allé 8, Karolinska Universitetssjukhuset, Huddinge
Time: 9.30
Department: Institutionen för laboratoriemedicin / Department of Laboratory Medicine
Abstract
Ataxia-telangiectasia is a rare autosomal recessive disorder characterized by cerebellar degeneration with ataxia, ocular and cutaneous telangiectasias, radiosensitivity, chromosomal instability, immunodeficiency, and cancer predisposition in both patients and heterozygous carriers of the gene. The gene responsible for the disorder, ATM, has been identified as a member of a family of phosphatidylinositol 3-kinaserelated genes and is one of the master controllers of the networks that are involved in cell cycle control and response to DNA damage.
In an attempt to investigate the functions of ATM, we have first identified the Swedish patients with the disorder and studied the Nordic A-T families for mutations in the ATM gene. We have also studied the role of ATM mutations in the pathogenesis of B-cell chronic lymphocytic leukemia and found that ATM inactivation is not a common or essential event in the pathogenesis of the vast majority of patients.
The immunopathogenic mechanism linking ATM dysfunction and immunodeficiency has not yet been established. The fact that the mechanisms involved in maintaining the genome stability are also utilized during lymphocyte development to create immune diversity, lead us to study class switch recombination in patients with ataxia-telangiectasia and related disorders Nijmegen breakage syndrome, ataxiatelangiectasia like disorder and Seckel syndrome, with mutations in NBS1, MRE11 and ATR, respectively.
We performed a detailed analysis of breakpoints resulting from in vivo switching from µ to alpha in the patients to study the nonhomologous end joining during class switch recombination. The switch junctions in all patient groups showed a trend toward increased microhomology usage. We also found that ATM and ATR are likely to act in the same pathway, but during different phases of the process, and both are involved in generation of mutations at or close to the junctions, and the upstream Sµ region. In addition, the absence of NBS1 or MRE11, that together with RAD50 form the Mre11 complex, clearly reduces switching in patients. These findings suggest that ATM, ATR and the Mre 11 complex are involved in nonhomologous end joining during class switch recombination and are likely to have both common and independent roles in the process.
In an attempt to investigate the functions of ATM, we have first identified the Swedish patients with the disorder and studied the Nordic A-T families for mutations in the ATM gene. We have also studied the role of ATM mutations in the pathogenesis of B-cell chronic lymphocytic leukemia and found that ATM inactivation is not a common or essential event in the pathogenesis of the vast majority of patients.
The immunopathogenic mechanism linking ATM dysfunction and immunodeficiency has not yet been established. The fact that the mechanisms involved in maintaining the genome stability are also utilized during lymphocyte development to create immune diversity, lead us to study class switch recombination in patients with ataxia-telangiectasia and related disorders Nijmegen breakage syndrome, ataxiatelangiectasia like disorder and Seckel syndrome, with mutations in NBS1, MRE11 and ATR, respectively.
We performed a detailed analysis of breakpoints resulting from in vivo switching from µ to alpha in the patients to study the nonhomologous end joining during class switch recombination. The switch junctions in all patient groups showed a trend toward increased microhomology usage. We also found that ATM and ATR are likely to act in the same pathway, but during different phases of the process, and both are involved in generation of mutations at or close to the junctions, and the upstream Sµ region. In addition, the absence of NBS1 or MRE11, that together with RAD50 form the Mre11 complex, clearly reduces switching in patients. These findings suggest that ATM, ATR and the Mre 11 complex are involved in nonhomologous end joining during class switch recombination and are likely to have both common and independent roles in the process.
List of papers:
I. Laake K, Jansen L, Hahnemann JM, Brondum-Nielsen K, Lonnqvist T, Kaariainen H, Sankila R, Lahdesmaki A, Hammarstrom L, Yuen J, Tretli S, Heiberg A, Olsen JH, Tucker M, Kleinerman R, Borresen-Dale AL (2000). Characterization of ATM mutations in 41 Nordic families with ataxia telangiectasia. Hum Mutat. 16(3): 232-46.
Pubmed
II. Lahdesmaki A, Kimby E, Duke V, Foroni L, Hammarstrom L (2004). ATM mutations in B-cell chronic lymphocytic leukemia. Haematologica. 89(1): 109-110.
Pubmed
III. Pan Q, Petit-Frere C, Lahdesmaki A, Gregorek H, Chrzanowska KH, Hammarstrom L (2002). Alternative end joining during switch recombination in patients with ataxia-telangiectasia. Eur J Immunol. 32(5): 1300-8.
Pubmed
IV. Lahdesmaki A, Taylor AM, Chrzanowska KH, Pan-Hammarstrom Q (2004). Delineation of the role of the Mre11 complex in class switch recombination. J Biol Chem. Epub ahead of print.
Pubmed
V. Lahdesmaki A, Hammarstrom L, Riuz-Perez VL, Goodship JA, Pan-Hammarstrom Q (2004). Role of ATR in nonhomologous end joining during class switch recombination. [Submitted]
View record in Web of Science®
VI. Lahdesmaki A, Arinbjarnarson K, Arvidsson J, el Segaier M, Fasth A, Fernell E, Gustafsson D, Oxelius VA, Risberg K, Yuen J, Zetterlund P, von Zweigbergk M, Ahsgren I, Hammarstrom L (2000). Ataxia-telangiectasia surveyed in Sweden. Lakartidningen. 97(40): 4461-5, 4467. Swedish
Pubmed
I. Laake K, Jansen L, Hahnemann JM, Brondum-Nielsen K, Lonnqvist T, Kaariainen H, Sankila R, Lahdesmaki A, Hammarstrom L, Yuen J, Tretli S, Heiberg A, Olsen JH, Tucker M, Kleinerman R, Borresen-Dale AL (2000). Characterization of ATM mutations in 41 Nordic families with ataxia telangiectasia. Hum Mutat. 16(3): 232-46.
Pubmed
II. Lahdesmaki A, Kimby E, Duke V, Foroni L, Hammarstrom L (2004). ATM mutations in B-cell chronic lymphocytic leukemia. Haematologica. 89(1): 109-110.
Pubmed
III. Pan Q, Petit-Frere C, Lahdesmaki A, Gregorek H, Chrzanowska KH, Hammarstrom L (2002). Alternative end joining during switch recombination in patients with ataxia-telangiectasia. Eur J Immunol. 32(5): 1300-8.
Pubmed
IV. Lahdesmaki A, Taylor AM, Chrzanowska KH, Pan-Hammarstrom Q (2004). Delineation of the role of the Mre11 complex in class switch recombination. J Biol Chem. Epub ahead of print.
Pubmed
V. Lahdesmaki A, Hammarstrom L, Riuz-Perez VL, Goodship JA, Pan-Hammarstrom Q (2004). Role of ATR in nonhomologous end joining during class switch recombination. [Submitted]
View record in Web of Science®
VI. Lahdesmaki A, Arinbjarnarson K, Arvidsson J, el Segaier M, Fasth A, Fernell E, Gustafsson D, Oxelius VA, Risberg K, Yuen J, Zetterlund P, von Zweigbergk M, Ahsgren I, Hammarstrom L (2000). Ataxia-telangiectasia surveyed in Sweden. Lakartidningen. 97(40): 4461-5, 4467. Swedish
Pubmed
Issue date: 2004-04-08
Publication year: 2004
ISBN: 91-7349-900-5
Statistics
Total Visits
Views | |
---|---|
Functional ...(legacy) | 170 |
Functional ... | 99 |
Total Visits Per Month
September 2023 | October 2023 | November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | |
---|---|---|---|---|---|---|---|
Functional ... | 0 | 1 | 1 | 0 | 1 | 0 | 1 |
Top country views
Views | |
---|---|
United States | 54 |
Germany | 41 |
Sweden | 41 |
China | 33 |
South Korea | 10 |
Finland | 7 |
Ireland | 6 |
Russia | 6 |
Denmark | 4 |
Hong Kong | 3 |
Top cities views
Views | |
---|---|
Kiez | 15 |
Seoul | 10 |
Sunnyvale | 7 |
Dublin | 6 |
Karlstad | 6 |
Beijing | 5 |
University Park | 5 |
Mountain View | 4 |
Shenzhen | 4 |
Ashburn | 3 |